Swedish Pharmaceuticals & Biotech Strong Balance Sheet Stocks

Level Bio

Market Cap: SEK 29.0m

Designs, develops, and distributes diagnostics products in the Nordic region and internationally.

IRLAB Therapeutics

Market Cap: SEK 372.9m

IRLAB Therapeutics AB (publ) discovers and develops drugs for the treatment of Parkinson’s disease and other CNS disorders.

PExA

Market Cap: SEK 14.6m

Develops and commercializes diagnostic products in various respiratory diseases.

Vivesto

Market Cap: SEK 125.6m

Develops, produces, markets, and sells drugs in the field of human and veterinary oncology in Sweden.

Swedish Orphan Biovitrum

Market Cap: SEK 106.5b

A biopharma company, provides medicines in the areas of haematology, immunology, and specialty care in Europe, North America, the Middle East, Asia, and Australia.

DanCann Pharma

Market Cap: DKK 6.3m

A biopharmaceutical company, focuses on discovering, developing, manufacturing, and commercializing therapeutic cannabinoids in various disease areas.

Toleranzia

Market Cap: SEK 129.5m

A biotechnology company, develops and commercializes drugs for the treatment of autoimmune orphan diseases.

Diagonal Bio

Market Cap: SEK 15.8m

Operates as a biotechnology company in Sweden.

Lipidor

Market Cap: SEK 202.9m

A pharmaceutical development company, engages in the development of drugs for the treatment of psoriasis, acne vulgaris, bacterial skin infections, and atopic dermatitis.

AlzeCure Pharma

Market Cap: SEK 219.9m

Operates as a pharmaceutical company that develops drug therapies for the treatment of severe diseases and conditions that affect the central nervous system.